(Bloomberg) -- Catalent Inc. shares traded at their lowest in three years following cuts to its annual financial outlook that hurt investor confidence in the contract drug manufacturer. The ...
(Bloomberg) -- Life sciences company Danaher Corp. has expressed takeover interest in contract manufacturer Catalent Inc., according to people familiar with the matter. Most Read from Bloomberg ...
Novo Holdings’ deal will see the Danish fund manager fork over $16.5 billion for Catalent, which operates dozens of production sites across Asia, Europe, Latin America and North America. The ...
Danaher Corporation is a leading player in the life science industry, with strong financial performance despite many spin-offs. The healthcare industry is facing challenges due to weak funding and ...
Danaher Corporation DHR is scheduled to release first-quarter 2024 results on Apr 23, before market open. The company’s earnings surpassed the Zacks Consensus Estimate in each of the trailing ...
CRANBROOK, Mich. – Jeanne Zoli Danaher was born Aug, 19, 1934, the second child of Theodore and Emma Zoli of Torrington, Conn. Throughout her life, Jeanne was proud of her Italian heritage and ...
Danaher Corporation DHR is well poised for growth courtesy of strength across its end markets, strategic acquisitions and its focus on improving the product line and operational excellence.
Danaher Corp. engages in the design, manufacture, and marketing of professional, medical, industrial, and commercial products and services. It operates through the following segments ...
Danaher is based in the United States and engages in the sector 'Manufacturing'. Find out more about Danaher in our report focusing on the company's key figures and information. With this report ...